Highlights

Current 'overactive bladder' concept useful for commercial interests but not the patient’s

Tuesday, 17 January 2012- The overactive bladder syndrome has become an accepted way to simplify a complex array of symptoms and leads people to believe that an overactive bladder is an independent disease in itself.

“However,...

Edited by: JV

Pelvic exercises help men with overactive bladders, says US study

Monday, 19 December 2011- A new study shows men with overactive bladder may benefit from pelvic floor exercises long known to help women plagued by the problem. And the exercises worked as well as medications, researchers...

Edited by: JV

Comparative evaluation of the safety and efficacy of long-term use of anticholinergics in OAB patients

Tuesday, 1 November 2011- Overactive bladder (OAB) is a chronic disease, but comparative trials of anticholinergics, which are commonly used for treatment of OAB, have generally been performed for up to 12 weeks only. There is no...

Edited by: JV

Perception of bladder fullness and bladder volume in OAB patients

Friday, 23 September 2011- R. Heeringa and colleagues evaluated the reliability of the degree of urge and perception of bladder fullness scales, the relationship between the scales and bladder volume, and possible differences...

Edited by: JV

Social networks such as Facebook underused by healthcare professionals

Tuesday, 13 September 2011- K. Sajadi and H. B. Goldman conducted a study to assess the incontinence resources readily available for patients among social networks. They published their findings in an online edition of...

Edited by: JV

Videourodynamic changes of BoNT-A in patients with neurogenic bladder dysfunction

Monday, 5 September 2011- S. H. Alloussi and colleagues conducted a study to document the videourodynamic changes and the efficacy and safety profile of botulinum toxin A (BoNT-A, Dysport®) in neurogenic bladder dysfunction (NBD)...

Edited by: JV

Botox gets FDA approval for some types of overactive bladder

Friday, 26 August 2011- The Food and Drug Administration (FDA) has approved botulinum toxin type A (Botox) for treating bladder overactivity resulting from spinal cord injury or multiple sclerosis.

Sometimes called neurogenic...

Edited by: JV

Urinary incontinence in men after one-to-one pelvic-floor muscle training following RP

Monday, 1 August 2011- Urinary incontinence is common immediately after prostate surgery. Men are often advised to do pelvic-floor exercises, but evidence to support this is inconclusive.

C. Glazener and colleagues conducted a...

Edited by: JV

Urinary incontinence doubles risk of postpartum depression

Wednesday, 22 June 2011- Women with urinary incontinence after giving birth are almost twice as likely to develop postpartum depression as those without incontinence, according to a new study conducted by Canadian...

Edited by: JV

Role of Botox-A in refractory idiopathic OAB patients without detrusor overactivity

Monday, 20 June 2011- P. Kanagarajah and colleagues conducted a study to evaluate the efficacy of intradetrusor botulinum toxin-A (BTX-A) in idiopathic overactive bladder patients (OAB) refractory to anti-muscarinic therapy,...

Edited by: JV

Older adults say urinary incontinence has greater impact on QOL than other chronic conditions

Friday, 10 June 2011- Americans 65 and older say that urinary incontinence affects their quality of life physically, mentally and socially to a greater degree than diabetes, arthritis and many other chronic conditions, according...

Edited by: JV

Mixed results for new OAB drugs

Monday, 30 May 2011- Overactive bladder (OAB) symptoms declined significantly within four weeks after the start of treatment with the investigational beta-3 agonist mirabegron, data from a randomised, placebo-controlled trial...

Edited by: JV

Immediate effect on OAB symptoms following use of imidafenacin

Monday, 2 May 2011- One of the factors influencing the treatment compliance of patients with overactive bladder (OAB) symptoms is thought to be the time to reach clinical effectiveness after administering drugs.

Y. Kitagawa and...

Edited by: JV

Caffeine intake, and the risk of stress, urgency and urinary incontinence

Friday, 22 April 2011- Although caffeine consumption is common and generally believed to affect bladder function, little is known about caffeine intake and incident urinary incontinence. Y. Jura and colleagues conducted a study...

Edited by: JV

Assessing the efficacy and tolerability of trospium XR in OAB

Wednesday, 13 April 2011- Once-daily extended-release (XR) trospium chloride has been evaluated for the treatment of overactive bladder syndrome (OAB) in two 12-week randomised, double-blind, placebo-controlled studies. This...

Edited by: JV